Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. Siegel RL, Miller KD, Jemal A (2016) Cancer statistics. CA Cancer J Clin 66(1):7–30. https://doi.org/10.3322/caac.21332. (Epub 2016 Jan 7)
2. Morice P, Leary A, Creutzberg C, Abu-Rustum N, Darai E (2016) Endometrial cancer. Lancet 387(10023):1094–1108
3. Giampaolino P, Cafasso V, Boccia D, Ascione M, Mercorio A, Viciglione F, Palumbo M, Serafino P, Buonfantino C, De Angelis MC, Verrazzo P (2022) Fertility-sparing approach in patients with endometrioid endometrial cancer grade 2 stage IA (FIGO): a qualitative systematic review. Biomed Res Int 27:2022
4. Raffone A, Travaglino A, Zullo FM, Gencarelli A, Micheli M, Miranda S, De Franciscis P, Insabato L, Sardo AD, Zullo F, Bifulco G (2021) Predictive accuracy of progesterone receptor B in young women with atypical endometrial hyperplasia and early endometrial cancer treated with hysteroscopic resection plus LNG-IUD insertion. J Minim Invasive Gynecol 28(6):1244–1253
5. Hutt S, Tailor A, Ellis P, Michael A, Butler-Manuel S, Chatterjee J (2019) The role of biomarkers in endometrial cancer and hyperplasia: a literature review. Acta Oncol 58:342–352